Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304890982> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W4304890982 abstract "Objectives No standard treatment exists for branch atheromatous disease (BAD), and patients' conditions often worsen after thrombolytic therapy. We evaluated the safety and effectiveness of tirofiban after early neurological deterioration (END) development in patients receiving intravenous alteplase. Materials and methods Bleeding incidence, National Institute of Health Stroke Scale (NIHSS) score, and modified Rankin scale (mRS) score were assessed for patients with BAD receiving alteplase within 4.5 h of stroke onset. Results Among 193 patients, 119 (61.64%) did not experience exacerbation after thrombolytic treatment, 74 (38.34%) had END, 34 were treated with tirofiban after END, and 40 received standard treatment. On day 7 or at discharge, no cases of symptomatic cerebral hemorrhage were noted, and no patient died during the 90-day follow-up. Fifty-two of 74 patients (70.27%) had a good mRS score at 90 days. Among patients with END who received tirofiban, 27 (79.41%) had a good mRS score at 90 days, which was significantly better than that of the 18 cases that did not receive tirofiban after exacerbation (45%; P < 0.001). NIHSS scores were significantly lower 24 h, 48 h, and 7 days after tirofiban treatment in patients with exacerbation after thrombolytic therapy than in those without tirofiban treatment. Conclusions Patients with BAD have elevated risks of END after thrombolytic therapy. Compared with conventional oral antiplatelet aggregation drugs, tirofiban rescue therapy resulted in significantly better NIHSS and mRS scores without increased symptomatic cerebral hemorrhage rates." @default.
- W4304890982 created "2022-10-13" @default.
- W4304890982 creator A5014820030 @default.
- W4304890982 creator A5032764121 @default.
- W4304890982 creator A5042804558 @default.
- W4304890982 creator A5070704459 @default.
- W4304890982 creator A5080888541 @default.
- W4304890982 date "2022-10-13" @default.
- W4304890982 modified "2023-10-03" @default.
- W4304890982 title "Safety and efficacy of tirofiban after early neurological deterioration in patients with branch atheromatous disease receiving alteplase" @default.
- W4304890982 cites W1997737552 @default.
- W4304890982 cites W2000094543 @default.
- W4304890982 cites W2002505150 @default.
- W4304890982 cites W2008309611 @default.
- W4304890982 cites W2029561501 @default.
- W4304890982 cites W2051686734 @default.
- W4304890982 cites W2059261222 @default.
- W4304890982 cites W2116043572 @default.
- W4304890982 cites W2146996262 @default.
- W4304890982 cites W2159233098 @default.
- W4304890982 cites W2171165037 @default.
- W4304890982 cites W2219034706 @default.
- W4304890982 cites W2292308933 @default.
- W4304890982 cites W2417209867 @default.
- W4304890982 cites W2509299184 @default.
- W4304890982 cites W2514297902 @default.
- W4304890982 cites W2610254229 @default.
- W4304890982 cites W2765779394 @default.
- W4304890982 cites W2884891453 @default.
- W4304890982 cites W2896681318 @default.
- W4304890982 cites W2908675585 @default.
- W4304890982 cites W2977469126 @default.
- W4304890982 cites W3211570917 @default.
- W4304890982 doi "https://doi.org/10.3389/fstro.2022.968510" @default.
- W4304890982 hasPublicationYear "2022" @default.
- W4304890982 type Work @default.
- W4304890982 citedByCount "0" @default.
- W4304890982 crossrefType "journal-article" @default.
- W4304890982 hasAuthorship W4304890982A5014820030 @default.
- W4304890982 hasAuthorship W4304890982A5032764121 @default.
- W4304890982 hasAuthorship W4304890982A5042804558 @default.
- W4304890982 hasAuthorship W4304890982A5070704459 @default.
- W4304890982 hasAuthorship W4304890982A5080888541 @default.
- W4304890982 hasBestOaLocation W43048909821 @default.
- W4304890982 hasConcept C126322002 @default.
- W4304890982 hasConcept C127413603 @default.
- W4304890982 hasConcept C141071460 @default.
- W4304890982 hasConcept C2776335557 @default.
- W4304890982 hasConcept C2777014857 @default.
- W4304890982 hasConcept C2780400711 @default.
- W4304890982 hasConcept C2780645631 @default.
- W4304890982 hasConcept C2780931571 @default.
- W4304890982 hasConcept C3020199598 @default.
- W4304890982 hasConcept C42219234 @default.
- W4304890982 hasConcept C500558357 @default.
- W4304890982 hasConcept C541997718 @default.
- W4304890982 hasConcept C71924100 @default.
- W4304890982 hasConcept C78519656 @default.
- W4304890982 hasConceptScore W4304890982C126322002 @default.
- W4304890982 hasConceptScore W4304890982C127413603 @default.
- W4304890982 hasConceptScore W4304890982C141071460 @default.
- W4304890982 hasConceptScore W4304890982C2776335557 @default.
- W4304890982 hasConceptScore W4304890982C2777014857 @default.
- W4304890982 hasConceptScore W4304890982C2780400711 @default.
- W4304890982 hasConceptScore W4304890982C2780645631 @default.
- W4304890982 hasConceptScore W4304890982C2780931571 @default.
- W4304890982 hasConceptScore W4304890982C3020199598 @default.
- W4304890982 hasConceptScore W4304890982C42219234 @default.
- W4304890982 hasConceptScore W4304890982C500558357 @default.
- W4304890982 hasConceptScore W4304890982C541997718 @default.
- W4304890982 hasConceptScore W4304890982C71924100 @default.
- W4304890982 hasConceptScore W4304890982C78519656 @default.
- W4304890982 hasFunder F4320326670 @default.
- W4304890982 hasLocation W43048909821 @default.
- W4304890982 hasOpenAccess W4304890982 @default.
- W4304890982 hasPrimaryLocation W43048909821 @default.
- W4304890982 hasRelatedWork W2003938723 @default.
- W4304890982 hasRelatedWork W2015230330 @default.
- W4304890982 hasRelatedWork W2047967234 @default.
- W4304890982 hasRelatedWork W2067013231 @default.
- W4304890982 hasRelatedWork W2118496982 @default.
- W4304890982 hasRelatedWork W2333479806 @default.
- W4304890982 hasRelatedWork W2439875401 @default.
- W4304890982 hasRelatedWork W4238867864 @default.
- W4304890982 hasRelatedWork W4304890982 @default.
- W4304890982 hasRelatedWork W2525756941 @default.
- W4304890982 hasVolume "1" @default.
- W4304890982 isParatext "false" @default.
- W4304890982 isRetracted "false" @default.
- W4304890982 workType "article" @default.